Ocular Adverse Effects of Psychotropic Drugs: A Clinical Study of 20 Cases (2023–2025)
Abstract:
Purpose: To analyze the ocular adverse effects induced by psychotropic medications and describe their mechanisms according to drug classes.
Methods: A retrospective descriptive study involving 20 patients followed between January 2023 and June 2025 for ocular manifestations secondary to psychotropic therapy.
Results: The mean age was 49 years (18–72), with a female predominance (60%). Neuroleptics accounted for 40% of prescriptions, antidepressants for 30%, anxiolytics for 20%, and mood stabilizers for 10%. The most frequent ocular effects were dry eye (45%), accommodative disorders (25%), ocular hypertension or acute glaucoma (15%), corneal deposits (10%), and retinal changes (5%).
Conclusion: Psychotropic drugs may cause a wide range of ocular side effects. Early detection and collaboration between psychiatrists and ophthalmologists are essential to prevent visual complications.
KeyWords:
Psychotropics; Adverse effects; Eye; Glaucoma; Dry eye; Vision.
References:
- Fraunfelder FW. Ocular side effects of systemic drugs. Am J Ophthalmol. 2004;138:493–501.
- Marmor MF. Drug-induced ocular toxicity. N Engl J Med. 2020;382:1593–1602.
- Biousse V, Newman NJ. Neuro-ophthalmology and psychiatry: an interface. Curr Opin Neurol. 2016;29:70–78.
- Zengin MO, et al. Ocular findings in patients using antipsychotic drugs. Clin Ophthalmol. 2014;8:331–336.
- Aksoy D, et al. Anticholinergic effects on tear film and ocular surface. Curr Eye Res. 2018;43:112–118.
- Fraunfelder FW, et al. Chlorpromazine pigmentary retinopathy. Arch Ophthalmol. 2006;124:890–895.
- Kim JM, et al. Antidepressants and intraocular pressure: a review. J Glaucoma. 2021;30:889–896.
- Kinoshita J, et al. Phenothiazine-induced corneal deposits. Cornea. 2017;36:150–156.
- Korkmaz H, et al. Lithium-induced nystagmus and diplopia. Int J Psychiatry Clin Pract. 2019;23:289–292.
- Mahon GJ, et al. Psychotropic medication and ocular safety: recommendations for clinical practice. Eye. 2022;36:905–914.
- Rosenthal SJ, et al. Ocular adverse drug reactions: multidisciplinary approach. Ophthalmic Res. 2023;66:122–130.
- Biousse V, et al. Drug toxicity and the retina. Surv Ophthalmol. 2021;66:651–667.
- Chaudhry IA, et al. Mechanisms of psychotropic ocular effects. Curr Opin Ophthalmol. 2020;31:495–502.
- Lim SH, et al. Clinical protocols for drug-induced ocular monitoring. J Clin Ophthalmol. 2022;76:431–439.
- Rahman R, et al. Strategies for early detection of ocular toxicity in psychiatry. Eur J Ophthalmol. 2023;33:740–748.